{"id":"W3195404919","doi":"10.1016/s2213-8587(21)00203-5","title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","year":2021,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1502,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"British Heart Foundation","keywords":"Medicine; Type 2 diabetes; Meta-analysis; Glucagon-like peptide 1 receptor; Diabetes mellitus; MEDLINE; Internal medicine; Intensive care medicine; Bioinformatics; Pharmacology; Receptor; Endocrinology; Agonist","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}